GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Reckitt Benckiser Group PLC (LSE:RKT) » Definitions » Valuation Rank

Reckitt Benckiser Group (LSE:RKT) Valuation Rank


View and export this data going back to 2007. Start your Free Trial

What is Reckitt Benckiser Group Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Reckitt Benckiser Group Valuation Rank Related Terms

Thank you for viewing the detailed overview of Reckitt Benckiser Group's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Reckitt Benckiser Group Business Description

Address
103-105 Bath Road, Slough, Berkshire, GBR, SL1 3UH
Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold the number-one or -two positions in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating around 35% of sales from emerging markets.